Prediction and causal inference of hyperuricemia using gut microbiota.

Journal: Scientific reports
PMID:

Abstract

Hyperuricemia (HUA) is a symptom of high blood uric acid (UA) levels, which causes disorders such as gout and renal urinary calculus. Prolonged HUA is often associated with hypertension, atherosclerosis, diabetes mellitus, and chronic kidney disease. Studies have shown that gut microbiota (GM) affect these chronic diseases. This study aimed to determine the relationship between HUA and GM. The microbiome of 224 men and 254 women aged 40 years was analyzed through next-generation sequencing and machine learning. We obtained GM data through 16S rRNA-based sequencing of the fecal samples, finding that alpha-diversity by Shannon index was significantly low in the HUA group. Linear discriminant effect size analysis detected a high abundance of the genera Collinsella and Faecalibacterium in the HUA and non-HUA groups. Based on light gradient boosting machine learning, we propose that HUA can be predicted with high AUC using four clinical characteristics and the relative abundance of nine bacterial genera, including Collinsella and Dorea. In addition, analysis of causal relationships using a direct linear non-Gaussian acyclic model indicated a positive effect of the relative abundance of the genus Collinsella on blood UA levels. Our results suggest abundant Collinsella in the gut can increase blood UA levels.

Authors

  • Yuna Miyajima
    Department of Clinical Laboratory Science, Faculty of Health Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Shigehiro Karashima
    Institute of Liberal Arts and Science, Kanazawa University Kanazawa Japan.
  • Ren Mizoguchi
    Department of Health Promotion and Medicine of the Future, Kanazawa University, Kanazawa, Japan.
  • Masaki Kawakami
    School of Electrical Information Communication Engineering, College of Science and Engineering, Kanazawa University Kanazawa Japan.
  • Kohei Ogura
    Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
  • Kazuhiro Ogai
    Department of Bio-Engineering Nursing, Graduate School of Nursing, Ishikawa Prefectural Nursing University, Kahoku, Ishikawa, Japan.
  • Aoi Koshida
    Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
  • Yasuo Ikagawa
    Institute for Frontier Science Initiative, Kanazawa University, Kanazawa, Japan.
  • Yuta Ami
    Faculty of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama, Japan.
  • Qiunan Zhu
    Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Hiromasa Tsujiguchi
    Department of Hygiene and Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Akinori Hara
    Department of Hygiene and Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Shin Kurihara
    Faculty of Biology-Oriented Science and Technology, Kindai University, Kinokawa, Wakayama, Japan.
  • Hiroshi Arakawa
    Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Hiroyuki Nakamura
    Department of Hygiene and Public Health, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • Ikumi Tamai
    Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Hidetaka Nambo
    School of Electrical Information Communication Engineering, College of Science and Engineering, Kanazawa University Kanazawa Japan.
  • Shigefumi Okamoto
    Laboratory of Medical Microbiology and Microbiome, Department of Clinical Laboratory and Biomedical Sciences, Division of Health Sciences, Osaka University Graduate School of Medicine, 1-7 Yamadaoka, Suita, Osaka, 565-0871, Japan. sokamoto@sahs.med.osaka-u.ac.jp.